—
The global human albumin market analyst says a trend helping to propel market growth is the rise in non-therapeutic applications. Non-therapeutic applications of albumin are on a rise. Research is yet to evaluate the applications of albumin as an excipient for commercial use. Some areas where albumin can be employed are as a drug-formulating agent, an ingredient in vaccines and sealant in surgeries, and to coat medical devices and equipment. Though the current supply of albumin for non-therapeutic purposes is low, the high interest shown by the research institutes and pharmaceutical and biopharmaceutical companies in investigating the potential non-therapeutic uses of albumin are expected to drive the market.Complete report on human albumin market spread across 75 pages, analyzing 5 major companies and providing 42 data exhibits is now available at http://www.rnrmarketresearch.com/global-human-albumin-market-2016-2020-market-report.html
The demand for albumin is high in APAC in countries such as India and China. However, the uptake of this therapeutics is still less due to the lack of awareness about these products and their therapeutic uses. Thus, the awareness programs conducted by organizations such as PPTA, which includes International Plasma Awareness Week, to help increase the awareness about plasma donation and the different plasma protein therapies available, along with their potential uses.
According to the human albumin market report, a key driver is the high demand for human albumin in China. China is the largest market for albumin products. Albumin is being used as a volume replacement therapy and for treating kidney diseases, cirrhosis, and cancer. But the demand for plasma products, primarily albumin and immunoglobulins, is outstripping the supply. This is because of the stringent regulations imposed on the supply of raw materials and ban in the import of plasma products. Because of the increased demand for albumin products, the ban on import of plasma products did not include albumin. Order a copy of Global Human Albumin Market 2016-2020 report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=626327
The report categorizes the global human albumin market into four major segments by application. Fluid replacement or volume replacement is essential in individuals who have lost massive volumes of blood. Albumin therapy helps in restoring and maintaining the blood volumes. Albumin can be used in the form of a plasma expander during cardiopulmonary bypass surgeries or for treating sepsis in individuals with liver cirrhosis, burns, or critically-ill patients. The biochemical and biophysical properties of albumin make it an excellent platform for drug delivery. Albumin interacts with a number of receptors in the body such as gp18, gp30, gp60, FcRn, cubilin and, megalin, improving the half-life, stability, versatility, safety, and ease of manufacture of the drugs. Albumin is added as an ingredient in vaccines and primarily acts as a stabilizer, which helps the vaccines, remain unchanged. Both the human serum albumin and recombinant albumins are used as stabilizers in various vaccines.
The following companies are the key players in the global human albumin market: CSL Behring, Grifols, Baxalta, Octapharma, and Kedrion. Other prominent vendors in the human albumin market are: AADi, Ablynx, Albumedix, Ampio Pharmaceuticals, Azaya Therapeutics, Beijing Tiantan, Biotest, Bristol-Myers Squibb, Celgene, ConjuChem, GSK, Hebei Changshan Biochem Pharma, HiMedia Laboratories, Hualan Biological Engineering, InVittria, MedxBio, Merck, Mitsubishi Tanabe Pharma, NantBioScience, Novo Nordisk, Novozymes, Shanghai RAAS Blood Products, Sucampo Pharmaceuticals, Teva Pharmaceuticals, Thermo Fisher Scientific, Tianjin SinoBiotech & Beijing Bio-Fortune, Ventria Bioscience, and Yoshitomi Pharmaceutical.
Global Human Albumin Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. The report covers the present scenario and the growth prospects of the global human albumin market for 2016-2020.
About Us:
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Contact Info:
Name: Ritesh Tiwari
Email: Send Email
Organization: RnRMarketResearch
Phone: + 1 888 391 5441
Website: http://www.rnrmarketresearch.com/global-human-albumin-market-2016-2020-market-report.html
Release ID: 123315